SCHEMBL25258979

SCHEMBL25258979

Nc1cnc(Br)c(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
CFTR P13569 9/20 0.38
KMT2A Q03164 2/20 0.34
HTT P42858 1/20 0.34
PIK3CD O00329 1/20 0.34
ULK1 O75385 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KIF11 P52732 1/20 0.32
CA2 P00918 1/20 0.32
CHKA P35790 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28088055 0.87 CFTR (0.38) GLAPOLBGAATSHRCFTR
SCHEMBL21031807 0.78 GLA (0.45) GLAPOLBGAATSHRPIK3CD
SCHEMBL29601287 0.78 GLA (0.45) GLAPOLBGAATSHRPIK3CD
SCHEMBL29427052 0.78 HTT (0.41) CFTRKMT2AHTTHRH4IDO1
SCHEMBL1577509 0.78 HTT (0.41) CFTRKMT2AHTTHRH4IDO1
SCHEMBL25297210 0.77 CYP11B2 (0.35) CFTRIDO1
SCHEMBL909629 0.75 PIK3CD (0.57) GLAPOLBGAATSHRPIK3CD
SCHEMBL11183262 0.75 CFTR (0.35) CFTRKMT2AHTTALDH1A1MAPT
SCHEMBL19349268 0.75 GAA (0.42) GLAPOLBGAATSHRCFTR
SCHEMBL16760127 0.75 L3MBTL1 (0.41) GLACFTRHTTPIK3CDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340551-A1 SMALL MOLECULE MODULATORS OF STAT6 GILEAD SCIENCES INC (US) 2025-11-06 US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 US disclosed
US-20250059196-A1 TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2025-02-20 US disclosed
EP-4458819-A1 TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2024-11-06 EP disclosed
CN-118451068-A Tri-fused ring derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-08-06 CN disclosed
WO-2023125877-A1 TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 2023-07-06 WO disclosed
CN-116375683-A Diazole derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-07-04 CN disclosed
CN-103946221-B heterocyclic compounds for the treatment of cystic fibrosis 诺华股份有限公司 2016-08-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 GLA 618/4885POLB 3003/4885GAA 159/4885
US-20250340551-A1 SMALL MOLECULE MODULATORS OF STAT6 STAT6, STAT1, STAT5B GLA 1797/4885POLB 3678/4885GAA 1459/4885
US-20250059196-A1 TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF WEE1, CYP51A1, WEE2 GLA 2601/4885POLB 2864/4885GAA 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.